Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-06-27
2006-06-27
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S653000
Reexamination Certificate
active
07067502
ABSTRACT:
A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
REFERENCES:
patent: 5837699 (1998-11-01), Sequeira et al.
patent: 5874063 (1999-02-01), Briggner et al.
patent: 6030604 (2000-02-01), Trofast
patent: 0 642 992 (1995-03-01), None
patent: 93/11773 (1993-06-01), None
patent: 95/05805 (1995-03-01), None
patent: 95/20393 (1995-08-01), None
patent: 98/34595 (1998-08-01), None
patent: 98/41193 (1998-09-01), None
patent: 99/18971 (1999-04-01), None
patent: 00/15234 (2000-03-01), None
Barnes, “Efficacy of Inhaled Corticosteroids in Asthma”, J. Allergy Clin. Immunol., vol. 102, No. 4, Part 1, pp. 531-538 (1998).
Dal Negro et al., “Chronic Airways Obstruction—Responsiveness to Combined Pressurized Salbutamol-Beclomethasone Diproplonate (Ventolin Flogo*)”, Clin Trials J., vol. 20, No. 6, pp. 366-372 (1983).
Gennaro (Eds.) et al., Remington's Pharmaceutical Sciences, 18thEdition, pp. 1699-1701 and pp. 1706-1707 (1990).
Lipworth et al., “Effects of Treament with Formoterol on Bronchoprotection Against Methacholine”, Am. J. Med., vol. 104, pp. 431-438 (1998).
O'Connor, “Combination Therapy”, Pulmonary Pharmacology & Therapeutics, vol. 11, pp. 397-399 (1998).
Pauwels et al., “Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma”, N. Engl. J. Med., vol. 337, No. 20, pp. 1405-1411 (1997).
Clarke Jeremy Guy
Danahay Henry Luke
Hassan Ian Francis
Houghton Gregory C.
Hui San-Ming
Novartis AG
LandOfFree
Combinations of formoterol and mometasone furoate for asthma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations of formoterol and mometasone furoate for asthma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of formoterol and mometasone furoate for asthma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3682502